Correlation Between Bed Bath and Kura Oncology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bed Bath and Kura Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bed Bath and Kura Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bed Bath Beyond and Kura Oncology, you can compare the effects of market volatilities on Bed Bath and Kura Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bed Bath with a short position of Kura Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bed Bath and Kura Oncology.

Diversification Opportunities for Bed Bath and Kura Oncology

  Correlation Coefficient

Very good diversification

The 3 months correlation between Bed Bath and Kura Oncology is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Bed Bath Beyond and Kura Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kura Oncology and Bed Bath is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bed Bath Beyond are associated (or correlated) with Kura Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kura Oncology has no effect on the direction of Bed Bath i.e., Bed Bath and Kura Oncology go up and down completely randomly.

Pair Corralation between Bed Bath and Kura Oncology

Given the investment horizon of 90 days Bed Bath Beyond is expected to under-perform the Kura Oncology. In addition to that, Bed Bath is 1.83 times more volatile than Kura Oncology. It trades about -0.22 of its total potential returns per unit of risk. Kura Oncology is currently generating about -0.11 per unit of volatility. If you would invest  1,506  in Kura Oncology on July 3, 2022 and sell it today you would lose (140.00)  from holding Kura Oncology or give up 9.3% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
ValuesDaily Returns

Bed Bath Beyond  vs.  Kura Oncology

 Performance (%) 
Bed Bath Beyond 
Bed Bath Performance
7 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Bed Bath Beyond are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental drivers, Bed Bath showed solid returns over the last few months and may actually be approaching a breakup point.

Bed Bath Price Channel

Kura Oncology 
Kura Oncology Performance
0 of 100
Over the last 90 days Kura Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in November 2022. The current disturbance may also be a sign of long term up-swing for the company investors.

Kura Oncology Price Channel

Bed Bath and Kura Oncology Volatility Contrast

   Predicted Return Density   

Pair Trading with Bed Bath and Kura Oncology

The main advantage of trading using opposite Bed Bath and Kura Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bed Bath position performs unexpectedly, Kura Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kura Oncology will offset losses from the drop in Kura Oncology's long position.
Bed Bath vs. Best Buy Company
The idea behind Bed Bath Beyond and Kura Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Kura Oncology vs. Olympus Corp
Kura Oncology vs. Hoya Corp ADR
Kura Oncology vs. Alexandria Real Estate
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Transaction History
View history of all your transactions and understand their impact on performance
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
CEO Directory
Screen CEOs from public companies around the world
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing